<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02167906</url>
  </required_header>
  <id_info>
    <org_study_id>9356</org_study_id>
    <nct_id>NCT02167906</nct_id>
  </id_info>
  <brief_title>Impact of Hand Osteoarthritis on Arterial Stiffness</brief_title>
  <official_title>Impact of Hand Osteoarthritis on Arterial Stiffness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients affected by osteoarthritis (OA) have an increase overall mortality compared to the
      general population, mainly due to cardiovascular diseases. OA patients without cardiovascular
      risk have a 10 years cardiovascular events higher of around 15-30 %. Although the molecular
      mechanisms are still not well known, the structure and function of the vessel wall can be
      affected by several inflammatory and metabolic parameters during OA.These functional and
      structural changes of the arterial wall leads to arterial stiffness, measured by the
      pulse-wave velocity (PWV). PWV is the most widely used technique to assess arterial stiffness
      and has been shown to have predictive value for morbidity and mortality. In our study, we
      planned to compare arterial stiffness in OA patients with healthy subjects.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">September 2016</completion_date>
  <primary_completion_date type="Anticipated">September 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>carotid-femoral arterial stiffness</measure>
    <time_frame>within the first 15 days after inclusion</time_frame>
    <description>To assess the carotid-femoral arterial stiffness determined by measuring the PWV in patients with hand OA compared to healthy subjects.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>hand oa patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>assess the carotid-femoral arterial stiffness determined by measuring the PWV</description>
  </arm_group>
  <arm_group>
    <arm_group_label>without Hand OA patients</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>assess the carotid-femoral arterial stiffness determined by measuring the PWV</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>arterial stiffness measurement</intervention_name>
    <arm_group_label>hand oa patients</arm_group_label>
    <arm_group_label>without Hand OA patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with clinical hand OA defined according to the ACR (American College of
             Rheumatology) criteria.

          -  Patients with radiographic hand OA defined according to the Kellgren

          -  Lawrence criteria (≥ 2).

          -  Steady dose of statins for at least one month.

          -  Subject affiliated to a social security scheme

          -  Written informed consent

        Exclusion Criteria:

          -  Rheumatoid arthritis, psoriatic arthritis or other inflammatory arthritis diseases.

          -  History of arterial hypertension treated and / or uncontrolled (SBP &gt; 140 mmHg and DBP
             (diastolic blood pressure) &gt; 90 mmHg)

          -  Diabetes (fasting blood glucose &gt; 7 mmol/L)

          -  Obesity (BMI &gt; 35 kg/m²)

          -  Chronic renal failure defined by a glomerular filtration rate &lt;60 ml/min/1,73m ².

          -  Patient with uncontrolled cardiovascular disease or a personal history of
             cardiovascular events (myocardial infarction and angina, occlusive arterial disease,
             stroke)

          -  Pregnant or breastfeeding, or premenopausal and not taking an effective contraception
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yves Marie PERS, MD</last_name>
    <phone>04 67 33 72 31</phone>
    <email>ym-pers@chu-montpellier.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>UH Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34 295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yves-Marie PERS, MD</last_name>
      <phone>04 67 33 72 31</phone>
      <email>ym-pers@chu-montpellier.fr</email>
    </contact>
    <investigator>
      <last_name>Yves Marie PERS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 17, 2014</study_first_submitted>
  <study_first_submitted_qc>June 17, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2014</study_first_posted>
  <last_update_submitted>June 17, 2014</last_update_submitted>
  <last_update_submitted_qc>June 17, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 19, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

